Treatment of Early Supraglottic Squamous Cell Carcinoma With Advance Technologies
Recruiting
Observational Study
Supraglottic Squamous Cell Carcinoma
Early Stage (T1-T2, N0-N1,M0)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 108 (estimated)
- Sponsor
- Centre Hospitalier Universitaire UCLouvain Namur · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
In this project, the investigators will realize an observational, prospective, multicentric and international clinical trial, to objectively compare patients with SSCC according to 3 arms of treatment:
* Arm 1: Radiotherapy ± chemotherapy
* Arm 2: Trans-oral Laser Microsurgery (TLM)
* Arm 3: Trans-oral Robotic Surgery (TORS)
The main goal is to evaluate the efficacy of each treatment with four c…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Diagnosis of SSCC (with histological confirmation)
* cT1-T2 / cN0-N1/ M0 according to 8th TNM classification (UICC/AJCC)
* WITH a Multidisciplinary Tumor Board decision according to the NCCN or European guidelines
* Diagnostic imaging (Head and neck and pulmonary CT or PE…
Contacts